Welcome to our dedicated page for Ticketplus Ltd. SEC filings (Ticker: TP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ticketplus Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ticketplus Ltd.'s regulatory disclosures and financial reporting.
Ticketplus Ltd. (TP) reported that it, together with its Chilean subsidiary Ticketplus SpA, acquired 100% of Argentine ticketing company Autoentrada S.A. on September 18, 2026, with the parent acquiring 10% and the subsidiary 90%, making Autoentrada a subsidiary of Ticketplus.
The deal converts Autoentrada from a white-label partner using Ticketplus’s platform since 2019 into full operations, giving Ticketplus direct relationships with promoters and greater control over sales, payments, access and analytics in Argentina. This is Ticketplus’s first acquisition since its August 2026 IPO, and the company does not expect it to have a material impact on consolidated 2026 financial results.
Ticketplus Ltd. (TP) filed Prospectus Supplement No. 1 to its August 6, 2026 prospectus covering 1,875,000 Ordinary Shares registered under its Form F-1. The supplement adds information from a Form 6-K furnishing unaudited interim consolidated financial statements and an operating and financial review for the six months ended June 30, 2026 and 2025.
The Ordinary Shares trade on NYSE American under the symbol TP, with a $7.10 closing price on August 19, 2026. Ticketplus is identified as both an emerging growth company and a foreign private issuer, and highlights that investing in its securities involves a high degree of risk as described in its prospectus risk factors.
Ticketplus Ltd. (TP) reports strong interim growth for the six months ended June 30, 2026. Revenue rose to $22.8 million from $13.6 million, while net profit increased to $4.1 million from $1.6 million. Gross profit margin expanded from 38.7% to 49.0%, and EBITDA nearly doubled to $9.6 million, with EBITDA margin improving to 42.1%.
Cash and cash equivalents were $3.8 million against bank loans of about $14.7 million, reflecting continued use of debt to fund growth and software investment, including $9.7 million of capitalized development. After period-end, Ticketplus completed an IPO and partial over-allotment, raising net proceeds of roughly $15.7 million, which would have lifted pro forma cash to about $19.4 million, above total bank debt.
Ticketplus Ltd. (TP) reported that director Sutin Bleiberg Tania Ester acquired 11,111 Ordinary Shares through a grant of restricted share units. The units were awarded at a stated price of $0.00 per share and will be settled in Ordinary Shares upon vesting, bringing the director's reported direct holdings to 11,111 shares.
Ticketplus Ltd. (symbol: TP) is the issuer of record for a Form 4 filing submitted to the SEC.
Ticketplus Ltd. (TP) reported that Chief Financial Officer Jadue Musalem Joaquin Nicolas acquired 153,846 Ordinary Shares on 2026-08-10 through a grant or award. The shares are held indirectly by Medistat SpA, over which he serves as general manager with sole voting and dispositive power. Following this transaction, his indirect holdings reported in this form total 153,846 Ordinary Shares.
Ticketplus Ltd. (symbol TP) reported that director Christopher P. Gardner received an equity award. On 2026-08-10, Gardner acquired 11,111 ordinary shares through a grant of restricted share units, at a stated price of $0.0000 per share. According to the disclosure, these restricted share units will be settled in ordinary shares upon vesting, and Gardner’s directly held position after this award is 11,111 ordinary shares.
Ticketplus Ltd. (symbol TP) completed an initial public offering of 1,875,000 Ordinary Shares at an offering price of $8.00 per share, generating $15,000,000 in gross proceeds. Under the underwriting agreement with Roth Capital Partners, Bancroft Capital, and Public Ventures d/b/a MDB Capital, the underwriters purchased the shares at $7.44 per share, equal to 93% of the public offering price, on a firm commitment basis. The company also granted the underwriters a 45-day over-allotment option to buy up to 281,250 additional Ordinary Shares at the offering price, less underwriting discounts, commissions and a non-accountable expense allowance. The offering closed on August 10, 2026, and after these costs Ticketplus received net proceeds of approximately $13,800,000. The Ordinary Shares began trading on NYSE American under the symbol "TP" on August 7, 2026.
Ticketplus states that it intends to use the net proceeds for continued development and maintenance of its live entertainment technology platform and related products and services, international expansion and strategic acquisitions, sales and marketing, and working capital and general corporate purposes. Officers, directors and certain shareholders have agreed to a 180-day lock-up on sales or certain other dispositions of Ordinary Shares and related securities without the prior written consent of the underwriters’ representatives. In connection with the IPO, Ticketplus adopted an Amended and Restated Memorandum and Articles of Association, which became effective upon the effectiveness of the company’s Form F-1 registration statement on August 6, 2026.
Ticketplus Ltd. (TP), a Cayman Islands holding company for a Latin America–focused live-event ticketing platform, is conducting an initial public offering of 1,875,000 Ordinary Shares at $8.00 per share, for gross proceeds of $15,000,000. Net proceeds are expected to be about $13.1 million, to fund platform development, international expansion and acquisitions, sales and marketing, and general corporate purposes. The shares are approved for listing on NYSE American under the symbol TP, with a 45‑day over‑allotment option for 281,250 additional shares.
Ticketplus operates a full‑service primary ticketing business in Chile and a white‑label SaaS model across 11 countries. In 2025 it generated $29.46 million in revenue on $268.87 million of GMV, up from $17.96 million revenue in 2024, and reported net profit of $2.24 million. Preliminary Q1 2026 results show revenue of $9.49 million, GMV of $107.18 million and EBITDA margin of 44.6%.
As of the prospectus date, chair Yethro Dinamarca Santelices controls about 76.1% of voting power and is expected to retain about 61.7% after the offering, making Ticketplus a “controlled company”. The company is an emerging growth company and a foreign private issuer, which allows reduced U.S. reporting and governance requirements. Key risks disclosed include reliance on live-event volumes, competition in ticketing, substantial Chilean‑peso debt of about $13.2 million, cybersecurity and data‑privacy exposure, AI‑related regulatory and operational risks, and extensive international regulatory compliance obligations.